Accustem Sciences Ltd
OTC:ACUT
Cash Flow Statement
Cash Flow Statement
Accustem Sciences Ltd
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net Income |
(5)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(1)
|
(2)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
2
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| Cash from Operating Activities |
(3)
N/A
|
(2)
+35%
|
(2)
+11%
|
(1)
+13%
|
(1)
+22%
|
(1)
+12%
|
(1)
+31%
|
(1)
-8%
|
(0)
+32%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
|
| Cash from Financing Activities |
3
N/A
|
1
-81%
|
1
+64%
|
1
+37%
|
1
-18%
|
1
-9%
|
1
-30%
|
1
+15%
|
0
-37%
|
|
| Change in Cash | ||||||||||
| Net Change in Cash |
0
N/A
|
(1)
N/A
|
(1)
+43%
|
(0)
+76%
|
(0)
+56%
|
(0)
+55%
|
(0)
+52%
|
0
N/A
|
(0)
N/A
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
(3)
N/A
|
(2)
+35%
|
(2)
+11%
|
(1)
+13%
|
(1)
+22%
|
(1)
+12%
|
(1)
+31%
|
(1)
-8%
|
(0)
+32%
|
|